500 mg Nalidixic Acid Tablets USP

Get a Price/Quote

MOQ : 100 Pieces

500 mg Nalidixic Acid Tablets USP Specification

CAS No
389-08-2

Medicine Type
Allopathic

Assay
97.5% to 102.0% of label claim

Usage
Used to treat urinary tract infections

Indication
Urinary tract infections caused by susceptible bacteria

Pacakaging (Quantity Per Box)
10 x 10 tablets

Dosage Form
Tablet

Salt Composition
Nalidixic Acid 500 mg

Molecular Formula
C12H12N2O3

Storage
Store in a cool, dry place below 25C, protect from light and moisture

Appearance
White to off-white tablet

Expiration Date
36 months from manufacturing date

Grade
Pharmaceutical Grade

Dosage
500 mg

ATC Code
J01MB02

Route of Administration
Oral

Side Effects
Nausea, vomiting, rash, headache, visual disturbances

Identification
Each tablet contains Nalidixic Acid 500 mg

Contraindications
Contraindicated in infants under 3 months, pregnant women, and patients with history of hypersensitivity to nalidixic acid

Mechanism of Action
Inhibits bacterial DNA gyrase

Shelf Life
36 months

Tablet Color
White

Pack Type
Blister pack

WHO GMP Certified
Yes

Tablet Shape
Round

Prescription Status
Prescription only

500 mg Nalidixic Acid Tablets USP Trade Information

Minimum Order Quantity
100 Pieces

Supply Ability
2000 Pieces Per Day

Delivery Time
7 Days

About 500 mg Nalidixic Acid Tablets USP

Procure the splendiferous 500 mg Nalidixic Acid Tablets USP, crafted for blue-ribbon value in urinary tract infection management. With a grandiose pharmaceutical grade formulation (CAS No: 389-08-2), each round, white tablet offers 500 mg of Nalidixic Acid, ensuring optimal therapeutic results by inhibiting bacterial DNA gyrase. Securely blister packed and WHO GMP certified, these tablets promise reliable quality for every get. Prescription-only, they must be safeguarded below 25C, protected from light and moisture. Not recommended for infants under three months, pregnant women, or individuals with nalidixic acid hypersensitivity. Available for distributor, exporter, manufacturer, supplier, trader, and wholesaler partners in India.

Material Feature, Surface Compatibility, and Usage Type of Nalidixic Acid Tablets

Each 500 mg Nalidixic Acid Tablet USP embodies pharmaceutical-grade integrity with its splendiferous white, round presentation. The material feature is meticulously standardized, providing maximum safety and efficacy. These tablets are suitable for oral administration, ensuring straightforward application to treat urinary tract infections. Usage type is strictly prescription-based, maintaining strict regulatory compliance. Designed for efficient, targeted relief, they are blister packed for secure handling and prolonged shelf life, making procurement and management seamless for healthcare professionals.

Sample Policy and Market Reach: Domestic and International Shipping

Our sample policy is crafted to minimize expenditure for prospective partners, enabling swift evaluation and onboarding of this blue-ribbon product. Secure, reliable shipping procedures ensure that samples are dispatched promptly. Main domestic markets cover India's expansive healthcare landscape, while global ambitions target main export markets through express shipping, ensuring products are shipped rapidly and safely worldwide. Commitment to quality and speed ensures partners receive their Nalidixic Acid Tablets efficiently and reliably.

FAQ's of 500 mg Nalidixic Acid Tablets USP:

Q: How does 500 mg Nalidixic Acid Tablet work in treating urinary tract infections?

A: Nalidixic Acid tablets inhibit bacterial DNA gyrase, an essential enzyme for bacterial replication. By targeting this enzyme, the medication effectively halts the growth and spread of susceptible bacteria responsible for urinary tract infections.

Q: What is the recommended usage and dosage for Nalidixic Acid Tablets USP?

A: The tablets should be taken orally as prescribed by a healthcare professional. Each tablet contains 500 mg Nalidixic Acid, and the dosage should strictly adhere to the doctor's instructions based on the patient's condition and clinical requirements.

Q: When should Nalidixic Acid Tablets not be used?

A: Nalidixic Acid Tablets are contraindicated in infants under 3 months, pregnant women, and those with a history of hypersensitivity to nalidixic acid. Always consult a physician before starting this medication.

Q: Where should Nalidixic Acid Tablets be stored for optimal safety and efficacy?

A: Store the tablets in a cool, dry place below 25C, away from light and moisture to maintain their pharmaceutical quality throughout their 36-month shelf life.

Q: What are the main benefits of choosing WHO GMP certified Nalidixic Acid Tablets?

A: Selecting WHO GMP certified tablets assures high manufacturing standards, product safety, and efficacy, providing healthcare professionals and patients with blue-ribbon confidence in every dose.

Tell us about your requirement